MedTrace Logo

True Continuous ECG Monitoring (TCEM Study)

NCT01559246 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2019-04-18

No results posted yet for this study

Summary

The purpose of this study is to compare short term (up to 48 hours) traditional cardiac rhythm monitoring using a standard ambulatory Holter monitor versus long term (up to 14 days), continuous ambulatory cardiac rhythm monitoring using a new device cleared by the FDA (Zio® Patch), iRhythm Technologies, Inc., San Francisco CA) in patients with suspected cardiac arrhythmias.

Conditions

  • Cardiac Arrhythmia

Sponsors & Collaborators

  • iRhythm Technologies, Inc.

    lead INDUSTRY

Principal Investigators

  • Eric Topol, MD · Scripps Translational Science Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2012-11-30
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01559246 on ClinicalTrials.gov